NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









myNEO Therapeutics

myNEO Therapeutics

Private
BelgiumHealthcare & Life Scienceshttp://myneo.xyz/

Last Round

Accelerator

Jul 1, 2020

Total Funding Raised

$2.35M

Company Overview

myNEO Therapeutics is a biotechnology company that develops therapeutic cancer vaccines by applying artificial intelligence to identify novel cancer targets from the 'dark genome'.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Data as a Service

AI Layer

Infrastructure

Keywords

cancer immunotherapyAI drug discoveryneoantigen discoverydrug discovery platformpersonalized cancer vaccineoff-the-shelf cancer vaccineimmuno-oncologycomputational biologyin silico drug discoverydark genome analysistarget discoverymRNA vaccinegenomic data analysiscamyotopesimmunogenicity screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

myNEO Therapeutics Comparables

Compare myNEO Therapeutics with similar companies based on industry and business-model similarity.

myNEO Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Evaxion A/S
79%
Geneos Therapeutics
77%
Nouscom
77%

myNEO Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJul 1, 2020
GrantMar 2, 2020
SeedDec 27, 2018
SeedDec 27, 2018

myNEO Therapeutics Investors

Notable investors and investment history

myNEO Therapeutics investors
InvestorRounds
Start it @KBCAccelerator
VLAIOGrant
Novalis BiotechSeed
Endless Frontier LabsAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2020

    Received funding from Start it @KBC.

  • Mar 2, 2020

    $2.35M grant received from VLAIO

myNEO Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

myNEO Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about myNEO Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBelgium
Year Founded2018
Last FundingJul 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.